224 related articles for article (PubMed ID: 9006785)
61. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
Keinke O
Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
[TBL] [Abstract][Full Text] [Related]
62. Contractile mechanisms of gallbladder filling and emptying in dogs.
Abiru H; Sarna SK; Condon RE
Gastroenterology; 1994 Jun; 106(6):1652-61. PubMed ID: 8194713
[TBL] [Abstract][Full Text] [Related]
63. Hepatic bile entry into and transit pattern within the gallbladder lumen: a new quantitative cholescintigraphic technique for measurement of its concentration function.
Krishnamurthy GT; Krishnamurthy S
J Nucl Med; 2002 Jul; 43(7):901-8. PubMed ID: 12097460
[TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
Goetz TE; Munsiff IJ; McKiernan BC
J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
[TBL] [Abstract][Full Text] [Related]
65. Theophylline disposition after single-dose ingestion of a once-a-day preparation (Dilatrane A. P. 400 mg) with and without breakfast.
Jonkman JH; Grasmeijer G; Holland A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):633-7. PubMed ID: 3429067
[TBL] [Abstract][Full Text] [Related]
66. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
[TBL] [Abstract][Full Text] [Related]
67. Contraction and evacuation of the gallbladder studied simultaneously by ultrasonography and 99mTc-labeled diethyl-iminodiacetic acid scintigraphy.
Rådberg G; Asztély M; Moonen M; Svanvik J
Scand J Gastroenterol; 1993 Aug; 28(8):709-13. PubMed ID: 8210988
[TBL] [Abstract][Full Text] [Related]
68. Application of fibroin in controlled release tablets containing theophylline.
Katayama H; Issiki M; Yoshitomi H
Biol Pharm Bull; 2000 Oct; 23(10):1229-34. PubMed ID: 11041257
[TBL] [Abstract][Full Text] [Related]
69. Effects of growth hormone deficiency and recombinant growth hormone therapy on postprandial gallbladder motility and cholecystokinin release.
Moschetta A; Twickler TB; Rehfeld JF; van Ooteghem NA; Cabezas MC; Portincasa P; van Berge-Henegouwen GP; van Erpecum KJ
Dig Dis Sci; 2004 Mar; 49(3):529-34. PubMed ID: 15139510
[TBL] [Abstract][Full Text] [Related]
70. Unexpected relationship between plasma protein binding and the pharmacodynamics of 2-NAP, a CCK1-receptor antagonist.
Gerskowitch VP; Hodge J; Hull RA; Shankley NP; Kalindjian SB; McEwen J; Black JW
Br J Clin Pharmacol; 2007 May; 63(5):618-22. PubMed ID: 17052250
[TBL] [Abstract][Full Text] [Related]
71. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
[TBL] [Abstract][Full Text] [Related]
72. Effects of cisapride on gallbladder emptying and pancreatic polypeptide and cholecystokinin release in humans.
Meguro T; Shimosegawa T; Kikuchi Y; Koizumi M; Toyota T
J Gastroenterol; 1995 Apr; 30(2):237-43. PubMed ID: 7773354
[TBL] [Abstract][Full Text] [Related]
73. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
Dadashzadeh S; Tajerzaden H
Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
[TBL] [Abstract][Full Text] [Related]
74. Methods of measuring gallbladder motor functions--the need for standardization: scintigraphy.
Prandini N
Dig Liver Dis; 2003 Jul; 35 Suppl 3():S62-6. PubMed ID: 12974513
[TBL] [Abstract][Full Text] [Related]
75. Comparative pharmacodynamic-pharmacokinetic correlation of oral sustained-release theophylline formulation in adult asthmatics.
Devarajan PV; Sule PN; Parmar DV
Drug Dev Ind Pharm; 1999 Apr; 25(4):529-34. PubMed ID: 10194609
[TBL] [Abstract][Full Text] [Related]
76. [Effects of food intake on the pharmacokinetics, metabolism and urinary excretion of two sustained release theophylline preparations in nonanesthetized dogs].
Suzuki S; Sakumoto S; Miyazaki H; Taneike T
Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):361-8. PubMed ID: 2379886
[TBL] [Abstract][Full Text] [Related]
77. The effect of orally administered marbofloxacin on the pharmacokinetics of theophylline.
Hirt RA; Teinfalt M; Dederichs D; van den Hoven R
J Vet Med A Physiol Pathol Clin Med; 2003 Jun; 50(5):246-50. PubMed ID: 14567511
[TBL] [Abstract][Full Text] [Related]
78. Influence of food on the absorption of theophylline from a sustained release formulation (Somophyllin).
Pedersen S; Møller-Petersen J
Clin Allergy; 1985 May; 15(3):253-9. PubMed ID: 4006175
[TBL] [Abstract][Full Text] [Related]
79. Fraction of theophylline in sustained-release formulation which is absorbed from the large bowel.
Sommers DK; Meyer EC; van Wyk M; Moncrieff J
Eur J Clin Pharmacol; 1990; 38(2):171-3. PubMed ID: 1970960
[TBL] [Abstract][Full Text] [Related]
80. Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement.
Ziessman HA; Jones DA; Muenz LR; Agarval AK
J Nucl Med; 2003 Aug; 44(8):1263-6. PubMed ID: 12902416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
